{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:25:01Z","timestamp":1791570301486,"version":"4.3.4"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>Learning Objectives<\/jats:title>\n                  <jats:p>After completing this course, the reader will be able to: Discuss the different modalities of disease dissemination in nongastric marginal-zone B-cell MALT lymphoma.Explain the rationale for using extensive staging in nongastric marginal-zone B-cell MALT lymphoma.Assess the clinical features helpful to detect patients with nongastric marginal-zone B-cell MALT lymphoma who have a poor prognosis.<\/jats:p>\n                  <jats:p>Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.11-3-285","type":"journal-article","created":{"date-parts":[[2006,3,20]],"date-time":"2006-03-20T22:02:49Z","timestamp":1142892169000},"page":"285-291","source":"Crossref","is-referenced-by-count":59,"title":["Nongastric Marginal-Zone B-Cell MALT Lymphoma: Prognostic Value of Disease Dissemination"],"prefix":"10.1093","volume":"11","author":[{"given":"Luca","family":"Arcaini","sequence":"first","affiliation":[{"name":"a Division of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Burcheri","sequence":"additional","affiliation":[{"name":"a Division of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rossi","sequence":"additional","affiliation":[{"name":"b Division of Hematology, Ospedali Riuniti, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[{"name":"a Division of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paulli","sequence":"additional","affiliation":[{"name":"c Department of Pathology, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Boveri","sequence":"additional","affiliation":[{"name":"c Department of Pathology, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercole","family":"Brusamolino","sequence":"additional","affiliation":[{"name":"a Division of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Orlandi","sequence":"additional","affiliation":[{"name":"a Division of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Molteni","sequence":"additional","affiliation":[{"name":"d Division of Hematology, Niguarda Ca\u2019 Granda Hospital, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pulsoni","sequence":"additional","affiliation":[{"name":"e Department of Hematology, University \u201cLa Sapienza,\u201d Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Christina","family":"Cox","sequence":"additional","affiliation":[{"name":"f Azienda Ospedaliera S. Andrea, University \u201cLa Sapienza,\u201d Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorella","family":"Orsucci","sequence":"additional","affiliation":[{"name":"g Division of Hematology, Azienda Ospedaliera S. Giovanni Battista, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Fabbri","sequence":"additional","affiliation":[{"name":"h Division of Hematology, Policlinico \u201cS. Maria alle Scotte\u201d, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Frezzato","sequence":"additional","affiliation":[{"name":"i Department of Hematology, S. Bortolo Hospital, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Voso","sequence":"additional","affiliation":[{"name":"j Department of Hematology, Catholic University Medical School, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zaja","sequence":"additional","affiliation":[{"name":"k Division of Hematology, University of Udine, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Montanari","sequence":"additional","affiliation":[{"name":"a Division of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Pascutto","sequence":"additional","affiliation":[{"name":"a Division of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Morra","sequence":"additional","affiliation":[{"name":"d Division of Hematology, Niguarda Ca\u2019 Granda Hospital, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cortelazzo","sequence":"additional","affiliation":[{"name":"b Division of Hematology, Ospedali Riuniti, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lazzarino","sequence":"additional","affiliation":[{"name":"a Division of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2021122208191085100_R1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","volume":"89","author":"The Non-Hodgkin's Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"key":"2021122208191085100_R2","first-page":"241","article-title":"MALT lymphomas","volume-title":"Hematology (Am Soc Hematol Educ Program)","author":"Cavalli","year":"2001"},{"key":"2021122208191085100_R3","first-page":"307","article-title":"Clinical presentation and management of marginal zone lymphomas","volume-title":"Hematology (Am Soc Hematol Educ Program)","author":"Thieblemont","year":"2005"},{"key":"2021122208191085100_R4","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.1999.17.4.1254","article-title":"Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients","volume":"17","author":"Zinzani","year":"1999","journal-title":"J Clin Oncol"},{"key":"2021122208191085100_R5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"key":"2021122208191085100_R6","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"key":"2021122208191085100_R7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1054\/bjoc.2000.1308","article-title":"Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma","volume":"83","author":"Raderer","year":"2000","journal-title":"Br J Cancer"},{"key":"2021122208191085100_R8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3816\/CLM.2003.n.002","article-title":"Nongastric mucosa-associated lymphoid tissue lymphomas","volume":"3","author":"Thieblemont","year":"2003","journal-title":"Clin Lymphoma"},{"key":"2021122208191085100_R9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.thj.6200013","article-title":"The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting\u2013Airlie House, Virginia, November, 1997","volume":"1","author":"Harris","year":"2000","journal-title":"Hematol J"},{"key":"2021122208191085100_R10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"2021122208191085100_R11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"2021122208191085100_R12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","article-title":"Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma","volume":"17","author":"Tanimoto","year":"2006","journal-title":"Ann Oncol"},{"key":"2021122208191085100_R13","article-title":"Infection-associated lymphomas derived from marginal-zone B-cells: a model of antigen-driven lymphoproliferations","volume-title":"Blood","author":"Suarez","year":"2006"},{"key":"2021122208191085100_R14","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1200\/JCO.2005.05.018","article-title":"State-of-the-art therapeutics: marginal-zone lymphoma","volume":"23","author":"Bertoni","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122208191085100_R15","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","article-title":"High relapse rate in patients with MALT lymphoma warrants lifelong follow-up","volume":"11","author":"Raderer","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2021122208191085100_R16","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"2021122208191085100_R17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1200\/JCO.2005.02.050","article-title":"Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma","volume":"23","author":"O'Connor","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122208191085100_R18","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1200\/JCO.2004.00.8532","article-title":"Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma","volume":"23","author":"Raderer","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.11-3-285","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.11-3-285","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/11\/3\/285\/41850965\/oncolo_11_3_285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/11\/3\/285\/41850965\/oncolo_11_3_285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T13:36:07Z","timestamp":1640180167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/11\/3\/285\/6398176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.11-3-285","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,3,1]]},"published":{"date-parts":[[2006,3,1]]}}}